Foundation Medicine

Foundation Medicine is a biotechnology company specializing in comprehensive genomic profiling for cancer. They make money by offering diagnostic testing services that help oncologists tailor personalized treatment plans based on the genetic makeup of a patient's tumor. Founded in 2010, the company has been a pioneer in precision medicine and was acquired by Roche in 2018, enhancing its capabilities and global reach. Their flagship products include FoundationOne CDx and FoundationOne Liquid, which are widely used in clinical settings.

Recent Posts by Foundation Medicine

1-20 of 56